10x Genomics Inc (TXG)

Finanzdaten der 10x Genomics Inc-Aktie (TXG)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	19.74% 183.98	153.64	146.82	134.28	156.23
Cost Of Revenue	17.35% 68.20	58.12	47.21	35.90	36.83
Gross Profit	21.20% 115.78	95.53	99.61	98.39	119.41
Operating Expenses	10.17% 170.97	190.32	162.97	150.38	142.50
Interest Income/Expense	700.00% 0.008	0.001	0.005	0.019	0.125
Benefits Costs and Expenses	6.04% 230.58	245.39	207.59	183.94	172.64
Costs And Expenses	6.04% 230.58	245.39	207.59	183.94	172.64
Operating Income/Loss	41.78% -55.19	-94.80	-63.36	-51.99	-23.10
Nonoperating Income/Loss	181.55% 8.59	3.051	2.591	2.334	6.685
Income/Loss From Continuing Operations Before Tax	49.21% -46.60	-91.74	-60.77	-49.65	-16.41
Income Tax Expense/Benefit	89.53% 2.354	1.242	1.647	1.093	0.804
Income/Loss From Continuing Operations After Tax	47.36% -48.95	-92.99	-62.41	-50.75	-17.21
Net Income/Loss	47.36% -48.95	-92.99	-62.41	-50.75	-17.21
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.60% 0.472	117.73	116.71	115.62	0.3029
Diluted Average Shares	99.60% 0.472	117.73	116.71	115.62	0.3029
Basic Earnings Per Share	48.10% -0.41	-0.79	-0.53	-0.44	-0.15
Diluted Earnings Per Share	48.10% -0.41	-0.79	-0.53	-0.44	-0.15
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-